---
document_datetime: 2025-12-29 14:35:02
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/pixuvri.html
document_name: pixuvri.html
version: success
processing_time: 0.1088455
conversion_datetime: 2025-12-31 01:44:10.672725
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Pixuvri

[RSS](/en/individual-human-medicine.xml/65851)

##### Expired

This medicine's authorisation has expired

pixantrone dimaleate Medicine Human Expired

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Pixuvri](#news-on)
- [More information on Pixuvri](#more-information-on-pixuvri-538)
- [More information on Pixuvri](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

The marketing authorisation for Pixuvri (Pixantrone) expired on 12 June 2024 following the decision of the marketing authorisation holder, Les Laboratoires Servier, not to apply for a renewal of the marketing authorisation. Les Laboratoires Servier confirmed that it did not apply for renewal of the authorisation due to the lack of demand for this product. Pixuvri was granted marketing authorisation in the European Union (EU) on 10 May 2012 for the treatment of multiply relapsed or refractory aggressive non-Hodgkin lymphomas.

The marketing authorisation was a conditional marketing authorisation which was subsequently converted to a full marketing authorisation in 2019 and was valid for a 5-year period. Therapeutic alternatives are available throughout the European Union. The European Public Assessment Report (EPAR) for Pixuvri is updated to indicate that the marketing authorisation is no longer valid.

Pixuvri : EPAR - Summary for the public

Reference Number: EMA/299783/2012

English (EN) (106.41 KB - PDF)

**First published:** 31/05/2012

**Last updated:** 31/05/2012

[View](/en/documents/overview/pixuvri-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-529)

български (BG) (210.71 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/bg/documents/overview/pixuvri-epar-summary-public_bg.pdf)

español (ES) (111.42 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/es/documents/overview/pixuvri-epar-summary-public_es.pdf)

čeština (CS) (140.44 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/cs/documents/overview/pixuvri-epar-summary-public_cs.pdf)

dansk (DA) (95.85 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/da/documents/overview/pixuvri-epar-summary-public_da.pdf)

Deutsch (DE) (96.38 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/de/documents/overview/pixuvri-epar-summary-public_de.pdf)

eesti keel (ET) (154.52 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/et/documents/overview/pixuvri-epar-summary-public_et.pdf)

ελληνικά (EL) (219.06 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/el/documents/overview/pixuvri-epar-summary-public_el.pdf)

français (FR) (157.71 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/fr/documents/overview/pixuvri-epar-summary-public_fr.pdf)

italiano (IT) (98.75 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/it/documents/overview/pixuvri-epar-summary-public_it.pdf)

latviešu valoda (LV) (153.26 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/lv/documents/overview/pixuvri-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (141.13 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/lt/documents/overview/pixuvri-epar-summary-public_lt.pdf)

magyar (HU) (120.92 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/hu/documents/overview/pixuvri-epar-summary-public_hu.pdf)

Malti (MT) (141.26 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/mt/documents/overview/pixuvri-epar-summary-public_mt.pdf)

Nederlands (NL) (94.9 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/nl/documents/overview/pixuvri-epar-summary-public_nl.pdf)

polski (PL) (138.88 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/pl/documents/overview/pixuvri-epar-summary-public_pl.pdf)

português (PT) (154.37 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/pt/documents/overview/pixuvri-epar-summary-public_pt.pdf)

română (RO) (136.21 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/ro/documents/overview/pixuvri-epar-summary-public_ro.pdf)

slovenčina (SK) (124.99 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/sk/documents/overview/pixuvri-epar-summary-public_sk.pdf)

slovenščina (SL) (183.44 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/sl/documents/overview/pixuvri-epar-summary-public_sl.pdf)

Suomi (FI) (155.62 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/fi/documents/overview/pixuvri-epar-summary-public_fi.pdf)

svenska (SV) (106.47 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/sv/documents/overview/pixuvri-epar-summary-public_sv.pdf)

Pixuvri : EPAR - Risk-management-plan summary

English (EN) (128.11 KB - PDF)

**First published:** 02/09/2019

[View](/en/documents/rmp-summary/pixuvri-epar-risk-management-plan-summary_en.pdf)

## Product information

Pixuvri : EPAR - Product Information

English (EN) (1.16 MB - PDF)

**First published:** 31/05/2012

**Last updated:** 07/12/2021

[View](/en/documents/product-information/pixuvri-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-622)

български (BG) (4.26 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/bg/documents/product-information/pixuvri-epar-product-information_bg.pdf)

español (ES) (765.76 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/es/documents/product-information/pixuvri-epar-product-information_es.pdf)

čeština (CS) (4.45 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/cs/documents/product-information/pixuvri-epar-product-information_cs.pdf)

dansk (DA) (1.22 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/da/documents/product-information/pixuvri-epar-product-information_da.pdf)

Deutsch (DE) (1.67 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/de/documents/product-information/pixuvri-epar-product-information_de.pdf)

eesti keel (ET) (1.61 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/et/documents/product-information/pixuvri-epar-product-information_et.pdf)

ελληνικά (EL) (2.46 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/el/documents/product-information/pixuvri-epar-product-information_el.pdf)

français (FR) (822.25 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/fr/documents/product-information/pixuvri-epar-product-information_fr.pdf)

hrvatski (HR) (1.7 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/hr/documents/product-information/pixuvri-epar-product-information_hr.pdf)

íslenska (IS) (1.29 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/is/documents/product-information/pixuvri-epar-product-information_is.pdf)

italiano (IT) (1.3 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/it/documents/product-information/pixuvri-epar-product-information_it.pdf)

latviešu valoda (LV) (4.38 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/lv/documents/product-information/pixuvri-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.78 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/lt/documents/product-information/pixuvri-epar-product-information_lt.pdf)

magyar (HU) (1.82 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/hu/documents/product-information/pixuvri-epar-product-information_hu.pdf)

Malti (MT) (1.83 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/mt/documents/product-information/pixuvri-epar-product-information_mt.pdf)

Nederlands (NL) (1.46 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/nl/documents/product-information/pixuvri-epar-product-information_nl.pdf)

norsk (NO) (1.15 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/no/documents/product-information/pixuvri-epar-product-information_no.pdf)

polski (PL) (2.04 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/pl/documents/product-information/pixuvri-epar-product-information_pl.pdf)

português (PT) (1.74 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/pt/documents/product-information/pixuvri-epar-product-information_pt.pdf)

română (RO) (2.02 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/ro/documents/product-information/pixuvri-epar-product-information_ro.pdf)

slovenčina (SK) (4.37 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/sk/documents/product-information/pixuvri-epar-product-information_sk.pdf)

slovenščina (SL) (1.88 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/sl/documents/product-information/pixuvri-epar-product-information_sl.pdf)

Suomi (FI) (1.47 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/fi/documents/product-information/pixuvri-epar-product-information_fi.pdf)

svenska (SV) (1.41 MB - PDF)

**First published:**

31/05/2012

**Last updated:**

07/12/2021

[View](/sv/documents/product-information/pixuvri-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0050 09/11/2021

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Pixuvri : EPAR - All Authorised presentations

English (EN) (30.44 KB - PDF)

**First published:** 31/05/2012

**Last updated:** 31/05/2012

[View](/en/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-693)

български (BG) (69.84 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/bg/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_bg.pdf)

español (ES) (31.94 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/es/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_es.pdf)

čeština (CS) (61.74 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/cs/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (31.54 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/da/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (31.86 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/de/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (32.15 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/et/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (67.18 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/el/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_el.pdf)

français (FR) (30.91 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/fr/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (50.11 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/hr/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (39.52 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/is/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_is.pdf)

italiano (IT) (31.15 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/it/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (61.32 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/lv/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (60.54 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/lt/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (46.01 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/hu/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (72.54 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/mt/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (31.54 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/nl/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (39.47 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/no/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_no.pdf)

polski (PL) (60.71 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/pl/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_pl.pdf)

português (PT) (32.31 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/pt/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_pt.pdf)

română (RO) (60.34 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/ro/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (61.33 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/sk/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (31.15 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/sl/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (31.11 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/fi/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (32.02 KB - PDF)

**First published:**

31/05/2012

**Last updated:**

31/05/2012

[View](/sv/documents/all-authorised-presentations/pixuvri-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Pixuvri Active substance pixantrone dimaleate International non-proprietary name (INN) or common name pixantrone dimaleate Therapeutic area (MeSH) Lymphoma, Non-Hodgkin Anatomical therapeutic chemical (ATC) code L01DB11

### Pharmacotherapeutic group

Antineoplastic agents

### Therapeutic indication

Pixuvri is indicated as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas (NHL). The benefit of pixantrone treatment has not been established in patients when used as fifth-line or greater chemotherapy in patients who are refractory to last therapy.

## Authorisation details

EMA product number EMEA/H/C/002055 Marketing authorisation holder

Les Laboratoires Servier

Les Laboratoires Servier

Opinion adopted 16/02/2012 Marketing authorisation issued 10/05/2012 Expiry of marketing authorisation 12/06/2024 Revision 23

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Pixuvri : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (473.61 KB - PDF)

**First published:** 25/07/2012

**Last updated:** 07/12/2021

[View](/en/documents/procedural-steps-after/pixuvri-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

Pixuvri-H-C-2055-R-0046 : EPAR - Assessment report- Renewal

Reference Number: EMA/250839/2019

English (EN) (6.68 MB - PDF)

**First published:** 02/09/2019

[View](/en/documents/variation-report/pixuvri-h-c-2055-r-0046-epar-assessment-report-renewal_en.pdf)

Pixuvri-H-C-2055-PSUV-0015 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Reference Number: EMA/CHMP/500946/2014

English (EN) (101.37 KB - PDF)

**First published:** 06/10/2014

**Last updated:** 06/10/2014

[View](/en/documents/scientific-conclusion/pixuvri-h-c-2055-psuv-0015-epar-scientific-conclusions-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

## Initial marketing authorisation documents

Pixuvri : EPAR - Public assessment report

Adopted

Reference Number: EMA/309145/2012

English (EN) (2.36 MB - PDF)

**First published:** 31/05/2012

**Last updated:** 31/05/2012

[View](/en/documents/assessment-report/pixuvri-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Pixuvri

Adopted

Reference Number: EMA/CHMP/102366/2012

English (EN) (80.58 KB - PDF)

**First published:** 17/02/2012

**Last updated:** 17/02/2012

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-pixuvri_en.pdf)

#### News on Pixuvri

[European Medicines Agency recommends conditional approval of Pixuvri (pixantrone) for relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma](/en/news/european-medicines-agency-recommends-conditional-approval-pixuvri-pixantrone-relapsed-or-refractory-aggressive-non-hodgkins-b-cell-lymphoma) 17/02/2012

#### More information on Pixuvri

- [The European Medicines Agency review of pixantrone for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphomas: summary of the scientific assessment of the Committee for Medicinal Products for Human Use](http://theoncologist.alphamedpress.org/content/18/5/625.long)

#### More information on Pixuvri

- [EMEA-000713-PIP02-10-M05 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000713-pip02-10-m05)

**This page was last updated on** 10/07/2024

## Share this page

[Back to top](#main-content)